2026 Global Congress
Global Colorectal Cancer Congress
Join us for connection, insight, and impact. Registration is now open.
Join GCCA for the 2026 Global CRC Congress, November 5–6, two hybrid format days dedicated to collaboration, learning, and action to drive meaningful change in colorectal cancer outcomes worldwide.
The Global Colorectal Cancer Congress is the premier international event dedicated to advancing colorectal cancer advocacy, education, and collaboration. Bringing together patient advocates, healthcare professionals, researchers, policymakers, and industry partners from around the world, the Congress provides practical insights and the latest developments shaping colorectal cancer care.
Over two days, attendees will explore topics including:
- Prevention, risk reduction, and screening
- Biomarkers, precision medicine, and diagnostics
- Treatment innovation and quality of care
- Equity, access, and health system capacity
- Patient experience, survivorship, and supportive care
- Advocacy, policy, and global collaboration
Designed for a global audience, the Congress makes it easy to participate from anywhere. Live sessions will take place November 5 from 8:30 a.m. to 4:00 p.m. East Africa Time and November 6 from 8:00 a.m. to 12:00 p.m. East Africa Time.
Registration includes access to all live virtual sessions as well as on-demand recordings after the Congress, allowing participants to revisit presentations or watch sessions they may have missed. Simultaneous translation will be available, helping make the program accessible to participants from around the world. There is a limited in-person experience in Nairobi, Kenya.
More than a conference, the Global Colorectal Cancer Congress is a space to learn, connect, and strengthen the global colorectal cancer advocacy community. By bringing together diverse perspectives and expertise from across the world, the Congress fosters meaningful collaboration, inspires new ideas, and equips participants with the knowledge and connections needed to create lasting change. Because progress happens faster when we move forward together.
Not a member? No problem. You do not need to be a GCCA member to attend the Global CRC Congress. Interested in membership? Learn more.
Speakers
Dr. Partha Basu
Dr. Partha Basu is Head of the Early Detection & Prevention Branch at the International Agency for Research on Cancer, France. He graduated in Medicine in 1988, completed an MD in Gynecology, followed by post-doctoral training in Gynecological Oncology and a PhD in Clinical Oncology.
Before joining IARC in 2015, Dr. Basu served as Head of the Department of Gynecological Oncology at the National Cancer Institute, India. He is internationally recognized for research that has shaped several WHO guidelines and global recommendations in cancer prevention. His work has also driven technology development in the field, including thermal ablation for cervical precancer, HPV detection methods, and AI-assisted cervical neoplasia detection.
He was awarded Honorary Fellowships of the Royal College of Obstetricians & Gynaecologists (UK) in 2023 and Indian College of Obstetrics and Gynaecology in 2026. He is a Visiting Professor at Zhejiang Cancer Hospital affiliated to the Chinese Academy of Medical Sciences.
Dr. Joan-Paula Bor Malenya
Dr. Bor is a medical doctor and global health expert with extensive experience in clinical care, health systems strengthening, and healthcare management in Kenya’s public sector. She currently serves as the Head of the National Cancer Control Program at the Ministry of Health, where she leads initiatives across the cancer care continuum. She has been instrumental in shaping and implementing the National Cancer Control Strategy, cancer screening guidelines, and other key national health policies and programs, with a strong focus on prevention & early detection, contributing to Kenya’s progress toward Universal Health Coverage. A strong advocate for integration and collaboration, she is dedicated to realizing the vision of a Kenya free from the preventable burden of cancer. She holds a Master of Science in Global Health & Non-Communicable Diseases from University of Edinburgh.
.avif)
Helena Harnik
Helena, Co-Founder of The Synergist, is Programs Executive Director. She oversees several Synergist Programs including Women’s Health, the From Testing to Targeted Treatments Program and Sustainable Health and Well-being, and several European-funded projects including GUIDE.MRD, Gravitate Health and IMI ConcePTION.
Helena has previously worked at Sanofi Pasteur and Gerson Lehrman Group (GLG), demonstrating how to solve societal issues by connecting diverse people together. Helena has an International MBA from EM Lyon in France, and a Bachelor of Arts in English Literature (cum laude) from Williams College in the United States.
Apeksha Patel
Apeksha Patel is a Medical Director in Oncology at Novartis, where she leads medical strategy, evidence generation, and external scientific engagement across solid tumors. She is a recognized thought leader at the intersection of artificial intelligence and oncology, with a particular focus on how AI can enhance clinical decision-making, evidence generation, patient outcomes and healthcare delivery.
With more than 18 years of biopharmaceutical experience spanning oncology, rare diseases, immunology, neuroscience, and virology, Dr. Patel has led and contributed to the development and launch of multiple transformative therapies that have changed treatment paradigms in many complex and hard to treat diseases. She collaborates extensively with academic centers, technology innovators, clinicians, and patient advocacy organizations to explore the responsible integration of AI into cancer care.
A frequent speaker at national and international conferences, Dr. Patel is passionate about translating emerging technologies into meaningful outcomes for patients and healthcare professionals. At GCCA, she will discuss the evolving role of artificial intelligence in colorectal cancer care, and its implications in patient outcomes.
FAQs
November 5-6, 2026
The Congress will be hybrid. It is virtual, but there is a small in-person component taking place in Nairobi, Kenya.
The Congress will be a hybrid event, in-person and virtual for the first day and first half of the second day. The afternoon portion of the second day will be in-person only.
The time zone is East Africa Time. You can check your local time at www.worldtimebuddy.com
Yes. Register now to guarantee access to the program recordings.
There is no fee to attend the Congress, in-person or virtually.
You will need a stable internet connection, and a computer, tablet, or smartphone.
The primary language will be English, but simultaneous translation will be available via Wordly in over 60 languages.
Please email nicole@globalcca.org.
Please email jenn@globalcca.org.
Thank you to our 2026 Sponsors
